BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Diagnosis
8 results:

  • 1. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
    Mitobe Y; Matsuda KI; Sonoda Y
    Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-marker algorithms based on CXCL13, IL-10, sil-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
    Kleinegger F; Hofer E; Wodlej C; Golob-Schwarzl N; Birkl-Toeglhofer AM; Stallinger A; Petzold J; Orlova A; Krassnig S; Reihs R; Niedrist T; Mangge H; Park YN; Thalhammer M; Aigelsreiter A; Lax S; Garbers C; Fickert P; Rose-John S; Moriggl R; Rinner B; Haybaeck J
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):308-321. PubMed ID: 30419338
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Random Skin Biopsies Before brain Biopsy for Intravascular Large B-Cell Lymphoma.
    Yamada E; Ishikawa E; Watanabe R; Matsumura H; Sakamoto N; Ishii A; Tamaoka A; Hattori K; Obara N; Chiba S; Nakamagoe K; Matsuda M; Tsurubuchi T; Tomidokoro Y; Akutsu H; Zaboronok A; Shibuya M; Takano S; Matsumura A
    World Neurosurg; 2019 Jan; 121():e364-e369. PubMed ID: 30261371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
    Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
    Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
    Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
    BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Neurological disturbances caused by intravascular lymphomatosis].
    Mizutani T
    Brain Nerve; 2011 May; 63(5):443-9. PubMed ID: 21515923
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Intravascular lymphomatosis manifesting clinically as subacute encephalopathy].
    Tsuji H; Mochiduki A; Hosaka A; Yoshizawa T; Tamaoka A
    Rinsho Shinkeigaku; 2008 May; 48(5):328-32. PubMed ID: 18540379
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.